ARTV · NASDAQ
Artiva Biotherapeutics (ARTV) Stock Price & Fundamentals
Artiva Biotherapeutics (ARTV) closed at $954.01 on Oct 9, 2026, up 0.61% from the previous close of $948.26.
Share price, past year
1Y +5.21%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $954.01 |
| Sep 30, 2026 | $965.58 |
| Aug 31, 2026 | $908.60 |
| Jul 31, 2026 | $936.22 |
| Jun 30, 2026 | $946.24 |
| May 29, 2026 | $886.14 |
| Apr 30, 2026 | $915.47 |
| Mar 31, 2026 | $878.27 |
| Feb 27, 2026 | $917.02 |
| Jan 30, 2026 | $882.64 |
| Dec 31, 2025 | $888.52 |
| Nov 28, 2025 | $929.03 |
| Oct 31, 2025 | $868.37 |
Key statistics
- Market cap
- $46.64B
- P/E (TTM)
- —
- EPS (TTM)
- −$3.31
- Revenue (TTM)
- —
- Net income (TTM)
- −$90.82M
- Shares outstanding
- 48.9M
- Dividend yield
- —
- 52-week range
- $859.96 – $965.58
Artiva Biotherapeutics's market cap is $46.64B, based on a share price of $954.01 and 48.9M shares outstanding as of Jul 31, 2026.
Financials
Artiva Biotherapeutics reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Artiva Biotherapeutics reported a net loss of $83.87M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | −100.0% | −$83.87M | — | −$3.43 | −$79.34M |
| FY2024ended Dec 31, 2024 | $251.00K | −99.3% | −$65.37M | −26,045.0% | −$5.81 | −$55.67M |
| FY2023ended Dec 31, 2023 | $33.49M | — | −$28.72M | −85.8% | −$35.78 | −$50.69M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2024ended Mar 31, 2024 | $251.00K | — | — |
| Q3 FY2023ended Sep 30, 2023 | $26.66M | — | — |
| Q2 FY2023ended Jun 30, 2023 | $3.50M | — | — |
Company profile
- Name
- Artiva Biotherapeutics, Inc.
- Ticker
- ARTV
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 5505 Morehouse Drive, San Diego, CA 92121
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001817241
Recent SEC filings
- Sep 11, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 22, 2026
- May 19, 2026
- May 8, 2026
- May 8, 2026
- May 8, 2026
Frequently asked questions
What is Artiva Biotherapeutics's stock price?
Artiva Biotherapeutics (ARTV) closed at $954.01 on Oct 9, 2026, up 0.61% from the previous close of $948.26.
What is Artiva Biotherapeutics's market cap?
Artiva Biotherapeutics's market cap is $46.64B, based on a share price of $954.01 and 48.9M shares outstanding as of Jul 31, 2026.
How much revenue does Artiva Biotherapeutics make?
Artiva Biotherapeutics reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Does Artiva Biotherapeutics pay a dividend?
Artiva Biotherapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Artiva Biotherapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures